EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie (Phase II)Open Access · CC BY-NC-ND 4.0

Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm

Jeremy N Ruskin, A John Camm, Christopher Dufton, Anderson C Woite-Silva, Ype Tuininga, Erik Badings, Jonas S S G De Jong, Thomas Oosterhof, Ismail Aksoy, Aaf F M Kuijper, Isabelle C Van Gelder, Vincent van Dijk und 8 weitere

JACC: Clinical Electrophysiology · 2024

DOI: 10.1016/j.jacep.2024.02.021 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2024. Verfasst von Jeremy N Ruskin und 19 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: jruskin@mgh.harvard.edu. Hauptthemen laut MEDLINE: Atrial Fibrillation, Flecainide, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationFlecainideAnti-Arrhythmia AgentsHumansFemaleMaleMiddle AgedAgedAdministration, InhalationAdministration, OralTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationcardioversionflecainideinhalation

Substanzen

FlecainideAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: jruskin@mgh.harvard.edu.
  • St. George's University, London, United Kingdom.
  • InCarda Therapeutics, Newark, California, USA.
  • Deventer Hospital, Deventer, the Netherlands.
  • Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, the Netherlands.
  • Ziekenhuis Gelderse Vallei, Ede, the Netherlands.

Zitieren

APA

Ruskin, J. N., Camm, A. J., Dufton, C., Woite-Silva, A. C., Tuininga, Y., Badings, E., De Jong, J. S. S. G., Oosterhof, T., Aksoy, I., Kuijper, A. F. M., Van Gelder, I. C., van Dijk, V., Nuyens, D., Schellings, D., Lee, M. Y., Kowey, P. R., Crijns, H. J. G. M., Maupas, J., Belardinelli, L., & INSTANT Investigators (2024). Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2024.02.021

Vancouver

Ruskin JN, Camm AJ, Dufton C, Woite-Silva AC, Tuininga Y, Badings E, et al. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm. JACC: Clinical Electrophysiology. 2024. doi:10.1016/j.jacep.2024.02.021

BibTeX
@article{Ruskin2024,
  author = {Ruskin, Jeremy N and Camm, A John and Dufton, Christopher and Woite-Silva, Anderson C and Tuininga, Ype and Badings, Erik and De Jong, Jonas S S G and Oosterhof, Thomas and Aksoy, Ismail and Kuijper, Aaf F M and Van Gelder, Isabelle C and van Dijk, Vincent and Nuyens, Dieter and Schellings, Dirk and Lee, Mark Young and Kowey, Peter R and Crijns, Harry J G M and Maupas, Jean and Belardinelli, Luiz and INSTANT Investigators, INSTANT Investigators},
  title = {Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  doi = {10.1016/j.jacep.2024.02.021}
}
Kostenlos starten →